Though the microbiome's impact on immune system homeostasis is well documented, the effect of circulating T cells on the gut microbiome remains unexamined. We analyzed data from 50 healthy volunteers in a pilot trial of aspirin, using immunophenotyping and 16S rRNA sequencing to evaluate the effect of baseline T cells on microbiome changes over 6 weeks. We employed an unsupervised sparse canonical correlation analysis (sCCA) and used multivariable linear regression models to evaluate the association between selected T cell subsets and selected bacterial genera after adjusting for covariates. In the cross-sectional analysis, percentages of naïve CD4+ T cells were positively associated with a relative abundance of , and the percentage of activated CD8+ T cells was inversely associated with . In the longitudinal analysis, the baseline percentages of naïve CD4+ T cells and activated CD4+ T cells were inversely associated with a 6-week change in the relative abundance of and , respectively. The baseline percentage of terminal effector CD4+ T cells was positively associated with the change in . Notably, the microbiome taxa associated with T cell subsets exclusively belonged to the . These findings can guide future experimental studies focusing on the role of T cells in impacting gut microbiome homeostasis.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11241708 | PMC |
http://dx.doi.org/10.3390/ijms25136831 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!